PLEASANTON, Calif., Dec. 18,
2023 /PRNewswire/ -- Movano Health (Nasdaq:
MOVE), a pioneer in health technology, today announced that its
female first wearable, the Evie Ring, is now eligible for HSA/FSA
fund reimbursement.
"Securing eligibility for HSA/FSA fund reimbursement is
tantamount to our goal of making the Evie Ring accessible to as
many women as possible," said John
Mastrototaro, CEO of Movano Health. "We are thrilled to be
able to offer consumers an easier way to access a solution that can
elevate their overall health and well being."
On average, using HSA/FSA pre-tax dollars can save
consumers upwards of 30-50% on qualifying direct to consumer health
and wellness purchases. US consumers contribute an estimated
$150B into HSA/FSA accounts every
year. By meeting these compliance and eligibility standards, the
Evie Ring will now be able to serve an even larger population of
women.
Movano Health successfully launched the Evie Ring on
November 20, 2023 and will be
showcasing the solution at CES 2024, where it has been named a CES
Innovation Award Honoree in Wearables. The Evie Ring can be
purchased exclusively at www.eviering.com.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health
is developing a suite of purpose-driven healthcare solutions to
bring medical-grade, high-quality data to the forefront of consumer
health devices. Featuring modern form factors, Movano Health's
devices capture a comprehensive picture of a person's vital health
information and uniquely translate the data into personalized and
intelligent insights that empower consumers to live healthier and
more balanced lives. Movano Health's end-to-end solutions will soon
enable consumers and their healthcare professionals to utilize
daily medical-grade data as a tool to proactively monitor and
manage health outcomes. For more information on Movano
Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains
forward-looking statements concerning our expectations,
anticipations, intentions, beliefs, or strategies regarding the
future. These forward-looking statements are based on assumptions
that we have made as of the date hereof and are subject to known
and unknown risks and uncertainties that could cause actual
results, conditions, and events to differ materially from those
anticipated. Therefore, you should not place undue reliance on
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding plans with
respect to commercial launch of the Evie Ring; planned cost-cutting
initiatives; anticipated FDA clearance for the Evie Ring and other
products in development; expected future operating results; product
development and features, product releases, clinical trials and
regulatory initiatives; our strategies, positioning and
expectations for future events or performance. Important factors
that could cause actual results to differ materially from those in
the forward-looking statements are set forth in our most recent
Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q, and in our other reports filed with the Securities and
Exchange Commission, including under the caption "Risk
Factors." Any forward-looking statement in this release
speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-announces-hsafsa-eligibility-for-its-women-first-wearable-the-evie-ring-302017403.html
SOURCE Movano
